I’ve always believed the best way to tackle a problem was to first learn as much about the problem as possible. So when one of my closest friends died from an overdose in 2012, I dedicated a good deal of time and my career to learning about the dangerous phenomenon of overdose.
Heroin addiction. The term itself brings out feelings of discomfort, sadness, and heartache. It seems like everywhere we turn there is another story of an individual who died from a heroin overdose—a life lost, a family tormented.
Naloxone. This is the overdose reversal medicine, the injection or nasal spray which can bring an overdosing addict back from the brink of death. Naloxone truly is a miracle of modern medicine, but one might be surprised as to the controversy over the drug.
The U.S. struggles in the grip of an opioid crisis—perhaps the worst addiction epidemic that our nation has ever seen. And in the last few years, a new strain of opioids has entered the scene, creating a surge in the addiction crisis and a resulting spike in the death toll.
Starting in late 2017, the number of drug overdose deaths in the U.S. have finally begun to decline after decades of increases. But the reasons why might indicate that we are not actually getting to the root of this problem but only coping better with the symptoms.
In August of 2018, the National Institute on Drug Abuse published the CDC’s statistics for American drug overdose deaths for 2017. According to the research, more than seventy-two thousand people died from drug overdoses in 2017 alone, a new highest-ever in overdose deaths.
According to an new article in Scientific American , there is a big downside to the use of opioid blockers like naloxone and naltrexone in addiction recovery. It’s important that anyone recommending or endorsing the use of opioid blockers understand the full effects of these drugs.
For a mother of a person struggling with opioid addiction, there’s only one motivation: Saving her child’s life. For a number of pharmaceutical companies, there's an entirely different motivation: Raking in billions in profits from drugs that are more in demand because of the opioid epidemic.